Cargando…

Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival

BACKGROUND/METHODS: This study determines the co-expression of mammaglobin-A, vascular endothelial growth factor receptor-3 (VEGFR3) and Ki67 by immunohistochemistry (IHC) in tissue samples from 80 patients undergoing breast surgery (cancer or benign disease). The tissue expression was compared with...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Elizabeth, Whiteoak, Naomi, Hall, Louise, France, James, Wilson, Deborah, Bhaskar, Pudupalayam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595648/
https://www.ncbi.nlm.nih.gov/pubmed/31263371
http://dx.doi.org/10.1177/1178223419858957
_version_ 1783430436891918336
author Baker, Elizabeth
Whiteoak, Naomi
Hall, Louise
France, James
Wilson, Deborah
Bhaskar, Pudupalayam
author_facet Baker, Elizabeth
Whiteoak, Naomi
Hall, Louise
France, James
Wilson, Deborah
Bhaskar, Pudupalayam
author_sort Baker, Elizabeth
collection PubMed
description BACKGROUND/METHODS: This study determines the co-expression of mammaglobin-A, vascular endothelial growth factor receptor-3 (VEGFR3) and Ki67 by immunohistochemistry (IHC) in tissue samples from 80 patients undergoing breast surgery (cancer or benign disease). The tissue expression was compared with the tumour histopathology and Kaplan Meier 5-year survival analysis was performed. RESULTS: Positive breast tissue expression was observed in 53% samples for mammaglobin, 41% Ki67 and 65% VEGFR3 with a significant positive correlation between Ki67 and VEGFR3 co-expression. Ki67 and VEGFR3 expression correlated with the breast tumour grade and Ki67 expression also correlated with oestrogen receptor (ER) status. At 5 years post-operatively, 6/80 patients had died and 3 patients were alive but had cancer recurrence. High Ki67 expression significantly correlated with poor survival (disease-free and overall). CONCLUSIONS: In this study, VEGFR3 and Ki67 expression but not mammaglobin-A correlated with breast tumour pathology. Positive Ki67 expression was also associated with a poor 5-year survival outcome.
format Online
Article
Text
id pubmed-6595648
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-65956482019-07-01 Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival Baker, Elizabeth Whiteoak, Naomi Hall, Louise France, James Wilson, Deborah Bhaskar, Pudupalayam Breast Cancer (Auckl) Original Research BACKGROUND/METHODS: This study determines the co-expression of mammaglobin-A, vascular endothelial growth factor receptor-3 (VEGFR3) and Ki67 by immunohistochemistry (IHC) in tissue samples from 80 patients undergoing breast surgery (cancer or benign disease). The tissue expression was compared with the tumour histopathology and Kaplan Meier 5-year survival analysis was performed. RESULTS: Positive breast tissue expression was observed in 53% samples for mammaglobin, 41% Ki67 and 65% VEGFR3 with a significant positive correlation between Ki67 and VEGFR3 co-expression. Ki67 and VEGFR3 expression correlated with the breast tumour grade and Ki67 expression also correlated with oestrogen receptor (ER) status. At 5 years post-operatively, 6/80 patients had died and 3 patients were alive but had cancer recurrence. High Ki67 expression significantly correlated with poor survival (disease-free and overall). CONCLUSIONS: In this study, VEGFR3 and Ki67 expression but not mammaglobin-A correlated with breast tumour pathology. Positive Ki67 expression was also associated with a poor 5-year survival outcome. SAGE Publications 2019-06-26 /pmc/articles/PMC6595648/ /pubmed/31263371 http://dx.doi.org/10.1177/1178223419858957 Text en © The Author(s) 2019 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Baker, Elizabeth
Whiteoak, Naomi
Hall, Louise
France, James
Wilson, Deborah
Bhaskar, Pudupalayam
Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival
title Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival
title_full Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival
title_fullStr Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival
title_full_unstemmed Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival
title_short Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival
title_sort mammaglobin-a, vegfr3, and ki67 in human breast cancer pathology and five year survival
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595648/
https://www.ncbi.nlm.nih.gov/pubmed/31263371
http://dx.doi.org/10.1177/1178223419858957
work_keys_str_mv AT bakerelizabeth mammaglobinavegfr3andki67inhumanbreastcancerpathologyandfiveyearsurvival
AT whiteoaknaomi mammaglobinavegfr3andki67inhumanbreastcancerpathologyandfiveyearsurvival
AT halllouise mammaglobinavegfr3andki67inhumanbreastcancerpathologyandfiveyearsurvival
AT francejames mammaglobinavegfr3andki67inhumanbreastcancerpathologyandfiveyearsurvival
AT wilsondeborah mammaglobinavegfr3andki67inhumanbreastcancerpathologyandfiveyearsurvival
AT bhaskarpudupalayam mammaglobinavegfr3andki67inhumanbreastcancerpathologyandfiveyearsurvival